Dechra Pharmaceuticals Manufacturing to expand liquids, creams and ointments (LCO) department
The firm aims to create a cGMP-compliant, state-of-the-art facility
Dechra Pharmaceuticals Manufacturing, the manufacturing business of Dechra Pharmaceuticals, based in Skipton, North Yorkshire, has initiated a significant investment programme to realise a major expansion of its liquids, creams and ointments (LCO) department, with the aim of creating a globally cGMP compliant, state-of-the-art facility.
The expansion will include refurbishment of the existing building fabric, improved utilities and significant process equipment procurement. The new equipment will provide a major increase in manufacturing capability and capacity, estimated at five times the current level.
'Following our earlier FDA approval for solid dose production, and the recent refurbishment of our injections suite, focus is now moving to the LCO Department and a major expansion of this area will be carried out in the first half of 2014,' said Mike Annice, Managing Director of Dechra Pharmaceuticals Manufacturing.
'This is another step to DPM becoming a global supplier of pharmaceutical products.'
